Kevin McCulloch insider trades
Open-market stock purchases and sales by Kevin McCulloch, See Remarks at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Aug 1, 2024.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +96%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $250K |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $127K |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $120K |
| Aug 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $177K |
| Mar 12, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | $200K |
| Mar 12, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | $16 |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $504K |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $223K |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $201K |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | — |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | — |
| Jan 8, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $120K |
| Oct 2, 2025 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $6.1K |
Companies traded
- XERS Xeris Biopharma Holdings, Inc: 1 buy, 4 sales, last Sep 28, 2026